[3dem] NESBA Symposium and Mixer - April 10th, 2026, at Sanofi’s Cambridge site

[Claudio Catalano]

Hello everyone,

If you are in the New England area and interested in a symposium on how structure-based design has transformed vaccines and protein therapeutics using cryo-EM, we invite you to join us. The symposium will take place on April 10th, 2026, at Sanofi’s Cambridge site (450 Water Street, Cambridge, MA).
Final confirmed talks:

Huixian Wu (Pfizer)
“Harnessing Artificial Intelligence and Cryo-EM to Accelerate Structure-Based Drug Discovery”

Richard Martin (Invivyd)
“Targeting the SARS-CoV-2 Spike: A Rational Approach to Antibody Engineering”

Sandeep Kumar (SKumar Biotech Advisory LLC)
“Biopharmaceutical Informatics: A Strategic Vision to Improve the Productivity of Drug Discovery and Development Cycles”

Gabriele Corso (MIT/Boltz)
“Boltz: Towards Accurate Biomolecular Modeling and Design”

Madhu Sevvana (Sanofi)
“Integrating High-Throughput Cryo-EM with Machine Learning: Advancing Biologics Engineering Workflows”

Jason McLellan (UT Austin)
“Reverse Vaccinology 3.0”

There are few tickets left. Please register here:
https://urldefense.com/v3/__https://www.eventbrite.com/e/designing-structure-protein-therapeutics-and-vaccines-tickets-1981935422200?aff=oddtdtcreator__;!!Mih3wA!FJ9Vx6hdGwvDMdny8D90u-IalINVqHd9xpY4xxmTLQm7ji9Z6KfTwO_ER3GO8CVwITQs62zgFQATHms6ZmiweN_F846Wn8I$ 
For vendors and service providers, please contact Raj and George from NESBA for further information.

On behalf of NESBA and its members, we thank NanoImaging Services (NIS) for logistical support and Sanofi for hosting the event.

We also acknowledge the organizing committee: Claudio Catalano, Sarah Sulley, Kristin Rider, Maria Argiriadi, Ching-Lin Hsieh, and Joseph Batchelor.

Special thanks to our symposium sponsors: NanoImaging Services, Thermo Fisher Scientific, MiTeGen, Nuclera, Exciting Instruments, Cadence/OpenEye, Dr GPCR, Vertex.

The information transmitted by this email is intended only for the person or entity to which it is addressed. This email may contain proprietary, business-confidential and/or privileged material. If you are not the intended recipient of this message, be aware that any use, review, retransmission, distribution, reproduction or any action taken in reliance upon this message is strictly prohibited. If you received this in error, please contact the sender and delete the material from all computers.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.ncmir.ucsd.edu/pipermail/3dem/attachments/20260401/000482bc/attachment.html>